Advertisement Contracts Archives - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Contracts

August 9, 2024

Bavarian Nordic secures $156.8m US vaccine deal

The US Biomedical Advanced Research and Development Authority (BARDA) has awarded a contract, worth $156.8m, to Bavarian Nordic for the production of additional bulk product for the smallpox and mpox vaccine, JYNNEOS.

Bavarian Nordic secures $156.8m US vaccine deal